PUBLISHER: The Insight Partners | PRODUCT CODE: 1149576
PUBLISHER: The Insight Partners | PRODUCT CODE: 1149576
The spirometer market in South & Central America is expected to grow from US$ 61.90 million in 2022 to US$ 115.20 million by 2028. It is estimated to grow at a CAGR of 10.9% from 2022 to 2028.
The higher prevalence of respiratory disorders is related to the decrease in the size of the upper airway lumen in the aging population. Lung diseases are among the most common medical conditions. Further, millions of people are suffering from various types of respiratory diseases across the region.
Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions such as asthma and chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens. With the increasing prevalence of smoking in developing countries and the aging population in high-income countries, Incidences of COPD are projected to rise over the next forty years. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help treat respiratory disease patients. In such cases, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the market is witnessing positive growth with the increasing incidence of such respiratory diseases.
South & Central America Spirometer Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Spirometer Market Segmentation
The South & Central America spirometer market is segmented by type, technology, application, and country. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment dominated the market in 2022. By technology, the market is segmented into volume, flow, and peak flow. The flow segment dominated the market in 2022. By application, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. The chronic obstructive pulmonary disease segment dominated the market in 2022. Based on country, the market is segmented into Brazil, Argentina, and the rest of South & Central America. Further, Brazil dominated the market in 2022.
A few key players dominating the South & Central America spirometer market are Baxter International Inc.; COSMED Srl; Henry Schein, Inc.; ICU Medical Inc.; Teleflex Incorporated; and VYAIRE MEDICAL, INC.